Tianjin Pharmaceutical Da Ren Tang to Invest 493.6 Million Yuan in Tianjin Pharmaceutical Group Taiping Medicine

MT Newswires09-12

Tianjin Pharmaceutical Da Ren Tang (SGX:T14, SHA:600329) will inject 493.6 million yuan into Tianjin Pharmaceutical Group Taiping Medicine, according to a Wednesday filing on the Singapore Exchange.

The capital injection will be carried out through the transfer of Tianjin Pharmaceutical Da Ren Tang's 100% equity interest in Tianjin Zhongxin Medicine to Tianjin Pharmaceutical Group Taiping Medicine.

This move will create a joint venture with Tianjin Pharmaceutical Holdings, which will hold a 56.7% stake in Tianjin Pharmaceutical Group Taiping Medicine.

Price (SGD): S$2.05, Change: S$+0.020, Percent Change: +0.99%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2466902472?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-12 10:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2466902472","market":"sg","top_or_hot":-1,"title":"Tianjin Pharmaceutical Da Ren Tang to Invest 493.6 Million Yuan in Tianjin Pharmaceutical Group Taiping Medicine","media":"MT Newswires","content":"<html><body><p> Tianjin Pharmaceutical Da Ren Tang (SGX:T14, SHA:600329) will inject 493.6 million yuan into Tianjin Pharmaceutical Group Taiping Medicine, according to a Wednesday filing on the Singapore Exchange.</p><p>The capital injection will be carried out through the transfer of Tianjin Pharmaceutical Da Ren Tang's 100% equity interest in Tianjin Zhongxin Medicine to Tianjin Pharmaceutical Group Taiping Medicine.</p><p>This move will create a joint venture with Tianjin Pharmaceutical Holdings, which will hold a 56.7% stake in Tianjin Pharmaceutical Group Taiping Medicine.</p><p>Price (SGD): S$2.05, Change: S$+0.020, Percent Change: +0.99%</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tianjin Pharmaceutical Da Ren Tang to Invest 493.6 Million Yuan in Tianjin Pharmaceutical Group Taiping Medicine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTianjin Pharmaceutical Da Ren Tang to Invest 493.6 Million Yuan in Tianjin Pharmaceutical Group Taiping Medicine\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-12 10:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tianjin Pharmaceutical Da Ren Tang (SGX:T14, SHA:600329) will inject 493.6 million yuan into Tianjin Pharmaceutical Group Taiping Medicine, according to a Wednesday filing on the Singapore Exchange....</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK6079","symbol_name":"制药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2466902472","we_media_id":"1060499803","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2466902472","pubTimestamp":1726108847,"sourceInfo":null,"weMediaInfo":{"media_name":"MT Newswires","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1060499803","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Tianjin Pharmaceutical Da Ren Tang  will inject 493.6 million yuan into Tianjin Pharmaceutical Group Taiping Medicine, according to a Wednesday filing on the Singapore Exchange.The capital injection will be carried out through the transfer of Tianjin Pharmaceutical Da Ren Tang's 100% equity interest in Tianjin Zhongxin Medicine to Tianjin Pharmaceutical Group Taiping Medicine.This move will create a joint venture with Tianjin Pharmaceutical Holdings, which will hold a 56.7% stake in Tianjin Pharmaceutical Group Taiping Medicine.Price : S$2.05, Change: S$+0.020, Percent Change: +0.99%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK6079":"制药","BK6506":"制药与医学研究概念","T14.SI":"达仁堂"},"translate_title":"天津医药大仁堂向天津医药集团太平医药投资4.936亿元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"T14.SI":0.9},"content_text":"Tianjin Pharmaceutical Da Ren Tang (SGX:T14, SHA:600329) will inject 493.6 million yuan into Tianjin Pharmaceutical Group Taiping Medicine, according to a Wednesday filing on the Singapore Exchange.The capital injection will be carried out through the transfer of Tianjin Pharmaceutical Da Ren Tang's 100% equity interest in Tianjin Zhongxin Medicine to Tianjin Pharmaceutical Group Taiping Medicine.This move will create a joint venture with Tianjin Pharmaceutical Holdings, which will hold a 56.7% stake in Tianjin Pharmaceutical Group Taiping Medicine.Price (SGD): S$2.05, Change: S$+0.020, Percent Change: +0.99%","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2466902472"}